50 years of Uricult!

50 years of high quality

Uricult was introduced for the first time 50 years ago and has since then become a well-recognised trademark for its high quality. All Uricult dipslide products enable estimation of the microbial count and if needed, the growth can be cultured further from the Uricult slide for identification and susceptibility testing of the organisms. Susceptibility testing is important especially for patients with high risk for resistance and complications¹.

Over the years Uricult culture slides have developed to meet the changing user needs without losing any of the features which in first place made it a success all over the world. Orion Diagnostica now offers three different Uricult products: Classic Uricult for detection of urinary tract infections, Uricult Plus for detection of enterococci, and Uricult Trio for detection of E. coli.

Tackle antimicrobial resistance with Uricult

Urinary tract infections (UTIs) are among the most common infections in people, more so in women and girls². Culturing makes it possible to identify unusual or resistant organisms. As inappropriate use of antibiotics has been recognised as one of the major causes for the development of antimicrobial resistance, it is important, in UTI as in other infections, to prescribe antibiotics only when needed³. On-site diagnostic tests help to reduce antibiotic prescription⁴.

Uricult - easy and practical means of diagnosing urinary tract infections!

• On-site test - There is no need to transport urine sample
• Convenient for transport - Uricult slide will not undergo change during transport
• Easy to use - Urine culture can be carried out as soon as sample is taken, without additional equipment

Celebrate with us and check the Uricult 50 years campaign on our local websites!

References:

1. Sabih A, Leslie SW. Urinary Tract Infections, Complicated. [Updated 2018 Jan 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003 Feb;49(2):53-70
3. Nickel JC. Urinary tract infections and resistant bacteria. Meeting review. Rev.Urol. 2007;9(2):78-80.
4. O’Neill J. Tackling drug-resistant infections globally. Final report and recommendations. 2016. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf

Read more on Uricult